James Miller
Concepts (326)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung Neoplasms | 44 | 2020 | 2207 | 2.890 |
Why?
| Smoking | 20 | 2019 | 1457 | 1.320 |
Why?
| Bronchi | 13 | 2018 | 250 | 1.280 |
Why?
| Carcinoma in Situ | 5 | 2019 | 44 | 1.160 |
Why?
| Carcinoma, Squamous Cell | 10 | 2018 | 577 | 0.810 |
Why?
| Carcinogens | 4 | 2012 | 105 | 0.800 |
Why?
| Chemoprevention | 3 | 2019 | 88 | 0.760 |
Why?
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2012 | 88 | 0.760 |
Why?
| Lung | 16 | 2020 | 3672 | 0.660 |
Why?
| Carcinoma, Small Cell | 7 | 2008 | 159 | 0.530 |
Why?
| Bronchopulmonary Dysplasia | 2 | 2019 | 330 | 0.510 |
Why?
| Urethane | 3 | 2012 | 41 | 0.510 |
Why?
| Bronchoscopy | 9 | 2019 | 245 | 0.490 |
Why?
| Sputum | 8 | 2019 | 290 | 0.490 |
Why?
| Pulmonary Alveoli | 4 | 2012 | 376 | 0.480 |
Why?
| Iloprost | 2 | 2012 | 46 | 0.480 |
Why?
| Hyperplasia | 7 | 2011 | 166 | 0.480 |
Why?
| Precancerous Conditions | 7 | 2020 | 156 | 0.460 |
Why?
| Neprilysin | 3 | 1998 | 47 | 0.440 |
Why?
| Biomarkers, Tumor | 7 | 2015 | 1048 | 0.430 |
Why?
| Piperidines | 2 | 2012 | 163 | 0.420 |
Why?
| Antineoplastic Agents | 4 | 2013 | 1893 | 0.420 |
Why?
| Quinazolines | 2 | 2012 | 241 | 0.410 |
Why?
| Biopsy | 11 | 2019 | 1056 | 0.410 |
Why?
| DNA Copy Number Variations | 1 | 2011 | 156 | 0.370 |
Why?
| Genetic Markers | 1 | 2011 | 325 | 0.360 |
Why?
| Bombesin | 5 | 1998 | 14 | 0.360 |
Why?
| Amidohydrolases | 3 | 1998 | 29 | 0.350 |
Why?
| Carcinoma, Non-Small-Cell Lung | 7 | 2013 | 963 | 0.350 |
Why?
| Neurosecretory Systems | 4 | 2004 | 32 | 0.340 |
Why?
| Isotretinoin | 1 | 2009 | 22 | 0.330 |
Why?
| Mass Screening | 3 | 2008 | 1024 | 0.330 |
Why?
| Ki-67 Antigen | 3 | 2015 | 104 | 0.330 |
Why?
| Tocopherols | 1 | 2009 | 22 | 0.330 |
Why?
| Vasodilator Agents | 1 | 2011 | 308 | 0.330 |
Why?
| ErbB Receptors | 1 | 2012 | 557 | 0.320 |
Why?
| Membrane Proteins | 2 | 2008 | 1024 | 0.310 |
Why?
| Neovascularization, Pathologic | 6 | 2015 | 283 | 0.300 |
Why?
| Pulmonary Disease, Chronic Obstructive | 4 | 2018 | 1098 | 0.290 |
Why?
| Respiratory Mucosa | 2 | 2008 | 258 | 0.280 |
Why?
| Adenocarcinoma | 6 | 2012 | 799 | 0.270 |
Why?
| Hypoxia | 1 | 2012 | 937 | 0.270 |
Why?
| Middle Aged | 28 | 2019 | 26999 | 0.240 |
Why?
| Aged | 25 | 2019 | 19251 | 0.240 |
Why?
| Chromosomes, Human, Pair 3 | 4 | 2000 | 49 | 0.240 |
Why?
| Chromosome Aberrations | 4 | 2013 | 134 | 0.230 |
Why?
| Carcinoma, Bronchogenic | 2 | 2002 | 17 | 0.220 |
Why?
| Humans | 53 | 2020 | 115587 | 0.210 |
Why?
| Tomography, Spiral Computed | 1 | 2002 | 24 | 0.210 |
Why?
| Female | 33 | 2019 | 59913 | 0.210 |
Why?
| Sensitivity and Specificity | 10 | 2010 | 1718 | 0.200 |
Why?
| Double-Blind Method | 2 | 2019 | 1660 | 0.190 |
Why?
| Smokers | 2 | 2019 | 147 | 0.190 |
Why?
| Lung Diseases | 5 | 2015 | 710 | 0.190 |
Why?
| Small Cell Lung Carcinoma | 2 | 2012 | 77 | 0.190 |
Why?
| Placebos | 2 | 2019 | 198 | 0.190 |
Why?
| Male | 30 | 2019 | 55949 | 0.190 |
Why?
| Tomography, X-Ray Computed | 2 | 2020 | 2392 | 0.190 |
Why?
| Tumor Cells, Cultured | 6 | 1998 | 850 | 0.170 |
Why?
| Neuropeptides | 4 | 1998 | 65 | 0.170 |
Why?
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2020 | 106 | 0.170 |
Why?
| Remission Induction | 1 | 2019 | 240 | 0.160 |
Why?
| Peptides | 3 | 1996 | 864 | 0.160 |
Why?
| In Situ Hybridization, Fluorescence | 6 | 2010 | 310 | 0.150 |
Why?
| Blotting, Western | 4 | 2012 | 1153 | 0.150 |
Why?
| Lung Diseases, Obstructive | 1 | 1997 | 40 | 0.150 |
Why?
| Genes, p53 | 1 | 1997 | 62 | 0.150 |
Why?
| Antibodies, Monoclonal | 3 | 2010 | 1265 | 0.150 |
Why?
| Proteomics | 2 | 2015 | 859 | 0.140 |
Why?
| Point Mutation | 1 | 1997 | 217 | 0.140 |
Why?
| Immunohistochemistry | 8 | 2015 | 1642 | 0.140 |
Why?
| Mice | 10 | 2012 | 15052 | 0.130 |
Why?
| Radiation Injuries, Experimental | 1 | 1996 | 25 | 0.130 |
Why?
| Animals | 13 | 2013 | 32102 | 0.130 |
Why?
| Bradykinin | 1 | 1996 | 46 | 0.130 |
Why?
| Endopeptidases | 1 | 1996 | 72 | 0.130 |
Why?
| Chromosomal Instability | 2 | 2013 | 19 | 0.130 |
Why?
| Smoking Cessation | 1 | 2019 | 377 | 0.130 |
Why?
| Hyperoxia | 1 | 1996 | 97 | 0.120 |
Why?
| Risk Factors | 5 | 2019 | 8697 | 0.120 |
Why?
| Multiple Pulmonary Nodules | 1 | 2015 | 27 | 0.120 |
Why?
| Aged, 80 and over | 8 | 2015 | 6417 | 0.120 |
Why?
| Gene Expression | 3 | 1998 | 1435 | 0.120 |
Why?
| Mice, Transgenic | 5 | 2009 | 1970 | 0.120 |
Why?
| Antigens | 1 | 1996 | 323 | 0.120 |
Why?
| Methylcholanthrene | 2 | 2012 | 18 | 0.120 |
Why?
| Mutation | 4 | 2000 | 3364 | 0.120 |
Why?
| Butylated Hydroxytoluene | 2 | 2012 | 32 | 0.120 |
Why?
| Algorithms | 3 | 2020 | 1490 | 0.120 |
Why?
| Stem Cells | 1 | 2018 | 546 | 0.110 |
Why?
| Microarray Analysis | 1 | 2013 | 119 | 0.110 |
Why?
| Epithelium | 4 | 2018 | 297 | 0.110 |
Why?
| Intramolecular Oxidoreductases | 2 | 2004 | 56 | 0.110 |
Why?
| Biological Products | 1 | 1996 | 172 | 0.110 |
Why?
| Epithelial Cells | 3 | 2007 | 961 | 0.110 |
Why?
| Carcinoma, Large Cell | 1 | 2012 | 14 | 0.110 |
Why?
| Risk | 5 | 2012 | 819 | 0.110 |
Why?
| Cytochrome P-450 Enzyme System | 2 | 2004 | 108 | 0.110 |
Why?
| Case-Control Studies | 8 | 2012 | 3022 | 0.100 |
Why?
| Receptors, Bombesin | 1 | 2012 | 4 | 0.100 |
Why?
| Bronchoalveolar Lavage Fluid | 3 | 2002 | 608 | 0.100 |
Why?
| Volatile Organic Compounds | 1 | 2012 | 45 | 0.100 |
Why?
| Immunoenzyme Techniques | 1 | 2012 | 193 | 0.100 |
Why?
| Cell Division | 4 | 2000 | 759 | 0.100 |
Why?
| Veterans | 1 | 2002 | 1233 | 0.100 |
Why?
| Sleep Apnea Syndromes | 1 | 2012 | 74 | 0.100 |
Why?
| Proto-Oncogene Proteins c-myc | 1 | 2012 | 114 | 0.100 |
Why?
| Dose-Response Relationship, Drug | 2 | 2010 | 1870 | 0.100 |
Why?
| Chromosomes, Human, Pair 15 | 1 | 2011 | 53 | 0.090 |
Why?
| Eosinophilic Granuloma | 1 | 1990 | 3 | 0.090 |
Why?
| Epithelial-Mesenchymal Transition | 1 | 2012 | 167 | 0.090 |
Why?
| Adult | 16 | 2018 | 30718 | 0.090 |
Why?
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2012 | 225 | 0.090 |
Why?
| Antioxidants | 2 | 2012 | 533 | 0.090 |
Why?
| Disease Progression | 5 | 2018 | 2418 | 0.090 |
Why?
| Calcium | 1 | 1996 | 1103 | 0.090 |
Why?
| Genome-Wide Association Study | 2 | 2013 | 1217 | 0.090 |
Why?
| Predictive Value of Tests | 4 | 2009 | 1805 | 0.090 |
Why?
| Cell Line | 5 | 2013 | 2651 | 0.090 |
Why?
| Proteins | 1 | 1996 | 920 | 0.090 |
Why?
| Plants, Toxic | 1 | 1989 | 28 | 0.090 |
Why?
| Cell Proliferation | 2 | 2018 | 2194 | 0.090 |
Why?
| Somatomedins | 1 | 2009 | 29 | 0.090 |
Why?
| Intracellular Signaling Peptides and Proteins | 2 | 2011 | 388 | 0.080 |
Why?
| Chromosome Deletion | 1 | 1989 | 95 | 0.080 |
Why?
| Bronchial Neoplasms | 1 | 2009 | 14 | 0.080 |
Why?
| Neoplasms, Glandular and Epithelial | 1 | 2009 | 39 | 0.080 |
Why?
| Neoplasm Invasiveness | 4 | 2015 | 445 | 0.080 |
Why?
| GPI-Linked Proteins | 1 | 2008 | 54 | 0.080 |
Why?
| Respiratory System | 1 | 1989 | 141 | 0.080 |
Why?
| Airway Obstruction | 3 | 2009 | 168 | 0.080 |
Why?
| Fluorescence | 3 | 2009 | 154 | 0.080 |
Why?
| Inflammation | 1 | 2018 | 2499 | 0.070 |
Why?
| Alkaline Phosphatase | 1 | 2008 | 144 | 0.070 |
Why?
| Polymorphism, Genetic | 1 | 2011 | 621 | 0.070 |
Why?
| Spectral Karyotyping | 1 | 2007 | 5 | 0.070 |
Why?
| Fibroblasts | 3 | 1998 | 839 | 0.070 |
Why?
| Molecular Targeted Therapy | 1 | 2010 | 348 | 0.070 |
Why?
| Isoenzymes | 1 | 2008 | 285 | 0.070 |
Why?
| Proto-Oncogene Proteins p21(ras) | 1 | 2008 | 228 | 0.070 |
Why?
| Cell Transformation, Neoplastic | 1 | 2009 | 314 | 0.070 |
Why?
| Pulmonary Surfactants | 2 | 1999 | 101 | 0.070 |
Why?
| Early Detection of Cancer | 1 | 2010 | 340 | 0.070 |
Why?
| Exons | 2 | 1998 | 300 | 0.070 |
Why?
| Molecular Sequence Data | 5 | 1998 | 2790 | 0.070 |
Why?
| Follow-Up Studies | 2 | 2015 | 4440 | 0.070 |
Why?
| MicroRNAs | 1 | 2012 | 607 | 0.070 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2013 | 1918 | 0.070 |
Why?
| Biomarkers | 3 | 2010 | 3466 | 0.070 |
Why?
| ROC Curve | 3 | 2015 | 451 | 0.070 |
Why?
| Enzyme-Linked Immunosorbent Assay | 3 | 2005 | 795 | 0.060 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2008 | 374 | 0.060 |
Why?
| Recombinant Proteins | 3 | 1998 | 1243 | 0.060 |
Why?
| RNA, Messenger | 3 | 1998 | 2574 | 0.060 |
Why?
| Polymerase Chain Reaction | 3 | 1998 | 1000 | 0.060 |
Why?
| Protein Kinase Inhibitors | 1 | 2010 | 790 | 0.060 |
Why?
| Cytokines | 1 | 2012 | 1853 | 0.060 |
Why?
| Growth Hormone-Releasing Hormone | 1 | 2004 | 27 | 0.060 |
Why?
| Acromegaly | 1 | 2004 | 12 | 0.060 |
Why?
| Rats | 4 | 2004 | 5034 | 0.060 |
Why?
| Neoplasm Recurrence, Local | 1 | 2009 | 863 | 0.060 |
Why?
| Adrenocorticotropic Hormone | 1 | 2004 | 148 | 0.060 |
Why?
| Cross-Sectional Studies | 2 | 2018 | 4435 | 0.050 |
Why?
| Smoke | 1 | 2004 | 133 | 0.050 |
Why?
| Base Sequence | 3 | 1998 | 2114 | 0.050 |
Why?
| Solitary Pulmonary Nodule | 1 | 2002 | 25 | 0.050 |
Why?
| Metaplasia | 2 | 2018 | 54 | 0.050 |
Why?
| Sex Factors | 1 | 2007 | 1736 | 0.050 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2005 | 503 | 0.050 |
Why?
| Pulmonary Fibrosis | 2 | 1998 | 330 | 0.050 |
Why?
| Radiation Dosage | 1 | 2002 | 139 | 0.050 |
Why?
| Hospitals, Veterans | 1 | 2002 | 245 | 0.050 |
Why?
| Reproducibility of Results | 1 | 2008 | 2800 | 0.050 |
Why?
| Cohort Studies | 4 | 2015 | 4944 | 0.040 |
Why?
| Gene Expression Regulation | 1 | 1989 | 2353 | 0.040 |
Why?
| Feasibility Studies | 1 | 2002 | 741 | 0.040 |
Why?
| Amino Acid Sequence | 3 | 1994 | 2000 | 0.040 |
Why?
| Signal Transduction | 3 | 1998 | 4541 | 0.040 |
Why?
| Gastrin-Releasing Peptide | 2 | 1996 | 6 | 0.040 |
Why?
| Light | 1 | 2001 | 337 | 0.040 |
Why?
| Autocrine Communication | 1 | 1998 | 43 | 0.040 |
Why?
| gamma Catenin | 1 | 2018 | 17 | 0.040 |
Why?
| Desmoglein 3 | 1 | 2018 | 17 | 0.040 |
Why?
| Loss of Heterozygosity | 2 | 2013 | 41 | 0.040 |
Why?
| Gene Expression Profiling | 1 | 2005 | 1536 | 0.040 |
Why?
| DNA Primers | 2 | 1998 | 514 | 0.040 |
Why?
| Paracrine Communication | 1 | 1998 | 56 | 0.040 |
Why?
| Up-Regulation | 2 | 2005 | 820 | 0.040 |
Why?
| Bronchial Diseases | 1 | 2018 | 38 | 0.040 |
Why?
| Neoplasm Transplantation | 1 | 1998 | 235 | 0.040 |
Why?
| United States | 2 | 2011 | 12295 | 0.040 |
Why?
| Cell Cycle Checkpoints | 1 | 2018 | 84 | 0.040 |
Why?
| Time | 1 | 2018 | 72 | 0.040 |
Why?
| Vascular Cell Adhesion Molecule-1 | 1 | 1998 | 36 | 0.040 |
Why?
| Telangiectasia, Hereditary Hemorrhagic | 1 | 1998 | 10 | 0.040 |
Why?
| Polymorphism, Single-Stranded Conformational | 1 | 1997 | 27 | 0.040 |
Why?
| Genes, Tumor Suppressor | 1 | 1998 | 78 | 0.040 |
Why?
| Likelihood Functions | 1 | 1998 | 128 | 0.040 |
Why?
| Neoplasm Staging | 2 | 2012 | 1178 | 0.040 |
Why?
| Alveolitis, Extrinsic Allergic | 1 | 1998 | 92 | 0.040 |
Why?
| Polymorphism, Restriction Fragment Length | 1 | 1997 | 65 | 0.040 |
Why?
| DNA, Complementary | 1 | 1998 | 258 | 0.040 |
Why?
| Treatment Outcome | 1 | 2011 | 9159 | 0.040 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 1998 | 274 | 0.040 |
Why?
| Codon | 1 | 1997 | 86 | 0.040 |
Why?
| Introns | 1 | 1998 | 226 | 0.040 |
Why?
| Membrane Glycoproteins | 1 | 1999 | 431 | 0.040 |
Why?
| Mice, Nude | 1 | 1998 | 639 | 0.040 |
Why?
| Incidence | 3 | 2010 | 2335 | 0.040 |
Why?
| Machine Learning | 1 | 2020 | 321 | 0.030 |
Why?
| Immunoassay | 2 | 1998 | 97 | 0.030 |
Why?
| Enzyme Activation | 1 | 1998 | 793 | 0.030 |
Why?
| RNA, Neoplasm | 1 | 1996 | 80 | 0.030 |
Why?
| Image Processing, Computer-Assisted | 1 | 2020 | 691 | 0.030 |
Why?
| Mesothelioma | 1 | 1996 | 31 | 0.030 |
Why?
| Glycopeptides | 1 | 1996 | 43 | 0.030 |
Why?
| Antigens, CD | 2 | 1998 | 442 | 0.030 |
Why?
| Databases, Factual | 1 | 2020 | 1138 | 0.030 |
Why?
| Sequence Analysis, DNA | 1 | 1998 | 732 | 0.030 |
Why?
| Proto-Oncogene Proteins | 1 | 2018 | 609 | 0.030 |
Why?
| Cell Cycle Proteins | 1 | 2018 | 553 | 0.030 |
Why?
| Myelin Sheath | 1 | 1996 | 145 | 0.030 |
Why?
| Prospective Studies | 3 | 2012 | 6264 | 0.030 |
Why?
| Receptors, Peptide | 1 | 1994 | 21 | 0.030 |
Why?
| Rh-Hr Blood-Group System | 1 | 1994 | 10 | 0.030 |
Why?
| Liver Neoplasms | 1 | 1998 | 521 | 0.030 |
Why?
| Neoplasm Metastasis | 1 | 1996 | 526 | 0.030 |
Why?
| Erythrocyte Membrane | 1 | 1994 | 50 | 0.030 |
Why?
| Blotting, Southern | 1 | 1993 | 66 | 0.030 |
Why?
| Blotting, Northern | 1 | 1993 | 194 | 0.030 |
Why?
| Endoscopy | 1 | 2015 | 247 | 0.030 |
Why?
| Cells, Cultured | 2 | 2007 | 3914 | 0.030 |
Why?
| DNA, Neoplasm | 1 | 1993 | 157 | 0.030 |
Why?
| Colorado | 1 | 2002 | 4113 | 0.030 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 1147 | 0.030 |
Why?
| Solid Phase Microextraction | 1 | 2012 | 6 | 0.030 |
Why?
| Dinoprostone | 2 | 2004 | 186 | 0.030 |
Why?
| Fluorescent Antibody Technique | 1 | 1993 | 398 | 0.030 |
Why?
| Enzyme Inhibitors | 1 | 1996 | 757 | 0.030 |
Why?
| Breath Tests | 1 | 2012 | 83 | 0.030 |
Why?
| Gas Chromatography-Mass Spectrometry | 1 | 2012 | 125 | 0.030 |
Why?
| Cloning, Molecular | 1 | 1993 | 523 | 0.030 |
Why?
| Iceland | 1 | 2011 | 6 | 0.020 |
Why?
| Tumor Suppressor p53-Binding Protein 1 | 1 | 2011 | 12 | 0.020 |
Why?
| Respiratory Tract Diseases | 1 | 1992 | 142 | 0.020 |
Why?
| Spain | 1 | 2011 | 34 | 0.020 |
Why?
| Netherlands | 1 | 2011 | 64 | 0.020 |
Why?
| Rats, Sprague-Dawley | 1 | 1996 | 2262 | 0.020 |
Why?
| Cattle | 1 | 1993 | 935 | 0.020 |
Why?
| Administration, Oral | 1 | 2012 | 734 | 0.020 |
Why?
| Severity of Illness Index | 1 | 2018 | 2578 | 0.020 |
Why?
| Prognosis | 2 | 2012 | 3339 | 0.020 |
Why?
| Meta-Analysis as Topic | 1 | 2011 | 161 | 0.020 |
Why?
| Carrier Proteins | 1 | 1994 | 701 | 0.020 |
Why?
| Flow Cytometry | 1 | 1993 | 1083 | 0.020 |
Why?
| Receptor, IGF Type 1 | 1 | 2009 | 58 | 0.020 |
Why?
| Area Under Curve | 1 | 2010 | 278 | 0.020 |
Why?
| Cystic Fibrosis | 1 | 1998 | 957 | 0.020 |
Why?
| International Agencies | 1 | 2009 | 29 | 0.020 |
Why?
| Erythrocytes | 1 | 1994 | 589 | 0.020 |
Why?
| Pilot Projects | 1 | 2012 | 1377 | 0.020 |
Why?
| Chromatography, High Pressure Liquid | 1 | 1989 | 477 | 0.020 |
Why?
| Mass Spectrometry | 1 | 2010 | 645 | 0.020 |
Why?
| Genome, Human | 1 | 2009 | 352 | 0.020 |
Why?
| Models, Statistical | 1 | 2010 | 606 | 0.020 |
Why?
| Disease Models, Animal | 1 | 1996 | 3580 | 0.020 |
Why?
| Amino Acids | 1 | 1989 | 454 | 0.020 |
Why?
| Genotype | 1 | 2011 | 1786 | 0.020 |
Why?
| Receptors, Vascular Endothelial Growth Factor | 1 | 2005 | 104 | 0.020 |
Why?
| Genomics | 1 | 2009 | 645 | 0.010 |
Why?
| Epoprostenol | 1 | 2004 | 133 | 0.010 |
Why?
| Bronchiolitis | 1 | 2004 | 83 | 0.010 |
Why?
| Autoantibodies | 1 | 2010 | 1360 | 0.010 |
Why?
| Pituitary Neoplasms | 1 | 2004 | 157 | 0.010 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 930 | 0.010 |
Why?
| Fruit | 1 | 2003 | 127 | 0.010 |
Why?
| Vegetables | 1 | 2003 | 133 | 0.010 |
Why?
| Genetic Predisposition to Disease | 1 | 2011 | 2125 | 0.010 |
Why?
| Respiratory Function Tests | 1 | 2004 | 535 | 0.010 |
Why?
| Adenoma | 1 | 2004 | 187 | 0.010 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 746 | 0.010 |
Why?
| Weight Gain | 1 | 2004 | 453 | 0.010 |
Why?
| Regression Analysis | 1 | 2003 | 959 | 0.010 |
Why?
| Single-Blind Method | 1 | 2001 | 255 | 0.010 |
Why?
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2000 | 57 | 0.010 |
Why?
| Carcinoma | 1 | 2001 | 200 | 0.010 |
Why?
| RNA | 1 | 2005 | 819 | 0.010 |
Why?
| Retrospective Studies | 1 | 2015 | 12608 | 0.010 |
Why?
| Bronchoscopes | 1 | 1998 | 4 | 0.010 |
Why?
| Endoglin | 1 | 1998 | 20 | 0.010 |
Why?
| Random Allocation | 1 | 1998 | 337 | 0.010 |
Why?
| Reference Values | 1 | 1998 | 744 | 0.010 |
Why?
| Genetic Linkage | 1 | 1998 | 297 | 0.010 |
Why?
| Longitudinal Studies | 1 | 2003 | 2416 | 0.010 |
Why?
| Comorbidity | 1 | 2001 | 1473 | 0.010 |
Why?
| Diet | 1 | 2003 | 1072 | 0.010 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2000 | 449 | 0.010 |
Why?
| Linear Models | 1 | 1998 | 776 | 0.010 |
Why?
| Receptors, Cell Surface | 1 | 1998 | 356 | 0.010 |
Why?
| Young Adult | 1 | 2011 | 10470 | 0.010 |
Why?
| Analysis of Variance | 1 | 1998 | 1227 | 0.010 |
Why?
| Alleles | 1 | 1998 | 794 | 0.010 |
Why?
| Infant, Premature | 1 | 1998 | 477 | 0.010 |
Why?
| Risk Assessment | 1 | 2004 | 2987 | 0.010 |
Why?
| CD47 Antigen | 1 | 1994 | 21 | 0.010 |
Why?
| Chromatography, Affinity | 1 | 1994 | 83 | 0.010 |
Why?
| Endothelium, Vascular | 1 | 2000 | 845 | 0.010 |
Why?
| Moths | 1 | 1994 | 34 | 0.010 |
Why?
| Genes | 1 | 1994 | 224 | 0.010 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 1994 | 312 | 0.010 |
Why?
| Cytoplasm | 1 | 1994 | 255 | 0.010 |
Why?
| Chromosome Mapping | 1 | 1994 | 489 | 0.010 |
Why?
| Adolescent | 1 | 2011 | 17889 | 0.010 |
Why?
| Carcinoid Tumor | 1 | 1992 | 25 | 0.010 |
Why?
| Lymphocytes | 1 | 1994 | 344 | 0.010 |
Why?
| Transfection | 1 | 1994 | 866 | 0.010 |
Why?
| Mice, Inbred BALB C | 1 | 1994 | 1168 | 0.010 |
Why?
| Dyspnea | 1 | 1992 | 223 | 0.010 |
Why?
| Binding Sites | 1 | 1994 | 1177 | 0.010 |
Why?
| Fibrosis | 1 | 1992 | 457 | 0.010 |
Why?
| Phenotype | 1 | 1998 | 2829 | 0.010 |
Why?
| Aging | 1 | 1998 | 1631 | 0.000 |
Why?
| Infant, Newborn | 1 | 1998 | 5077 | 0.000 |
Why?
| Infant | 1 | 1998 | 7979 | 0.000 |
Why?
| Child, Preschool | 1 | 1998 | 9133 | 0.000 |
Why?
| Child | 1 | 1998 | 18488 | 0.000 |
Why?
|
|
Miller's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|